A family of molecules found in every cell turns out to have a hidden job — safely storing iron — and that discovery could open a new way to kill cancer cells.
Scientists at the Whitehead Institute (affiliated with MIT) found that polyamines act like “storage lockers” that keep iron in a stable, non-reactive form inside cells. When polyamine levels drop, chemically reactive iron rises — and that can be toxic. The work was published August 14, 2026 in Cell.
The cancer angle
Cancer cells rely on high polyamine levels to fuel their rapid growth, which may make them especially vulnerable to this mechanism. Using genome-wide CRISPR screening and a custom fluorescent iron sensor, the researchers propose that lowering polyamines while also blocking a protective protein called GPX4 could tip cancer cells into ferroptosis — a form of iron-driven cell death. “Combining drugs that lower polyamine levels with those that block GPX4 might be more effective for killing cancer cells than targeting either pathway alone,” said researcher Pushkal Sharma.
Beyond cancer
The finding may also shed light on early-onset Parkinson’s disease, where mutations in a polyamine-transport gene are linked to elevated iron in the brain. It is basic, mechanistic research — not a treatment — but it reframes polyamines as key gatekeepers of iron and hands drug developers a fresh combination strategy to test.